Contrast Medium Dose-to-GFR Ratio: A Measure of Systemic Exposure to Predict Contrast-Induced Nephropathy after Percutaneous Coronary Intervention

References

• Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002; 39: 930–6
   PubMed Web of Science ®Google Scholar
• McCullough PA, Adam A, Becker CR, Davidson C, Lameire N, Stacul F, et al. Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol ;:K 2006; 98: 5K–13
   PubMed Web of Science ®Google Scholar
• Marenzi G, Lauri G, Assanelli E, Campodonico J, De Metrio M, Marana I, et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2004; 44: 1780–5
   PubMed Web of Science ®Google Scholar
• McCullough PA, Adam A, Becker CR, Davidson C, Lameire N, Stacul F, et al. Risk prediction of contrast-induced nephropathy. Am J Cardiol ;:K 2006; 98: 27K–36
   PubMed Web of Science ®Google Scholar
• Mehran R, Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl 2006; 69: S11–5
   Google Scholar
• Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 1992; 38: 1933–53
   PubMed Web of Science ®Google Scholar
• National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S46–110.
   Google Scholar
• Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004; 44: 1393–9
   PubMed Web of Science ®Google Scholar
• Bartholomew BA, Harjai KJ, Dukkipati S, Boura JA, Yerkey MW, Glazier S, et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 2004; 93: 1515–9
   PubMed Web of Science ®Google Scholar
• Altmann D, Zwas D, Spatz A, Bergman G, Spokojny A, Riva S, et al. Use of the contrast volume estimated creatinine clearance ratio to predict renal failure after angiography. J Interv Cardiol 1997; 10: 113–9
   Google Scholar
• Chen M-L, Lekso L, Williams R. Measures of exposure versus measures of rate and extent of absorption. Clin Pharmacokinet 2001; 40: 565–72
   PubMed Web of Science ®Google Scholar
• Sherwin PF, Cambron R, Johnson JA, Pierro JA. Contrast dose-to-creatinine clearance ratio as a potential indicator of risk for radiocontrast-induced nephropathy: correlation of D/CrCL with area under the contrast concentration-time curve using iodixanol. Invest Radiol 2005; 40: 598–603
   PubMed Web of Science ®Google Scholar
• Nyman U, Almen T, Aspelin P, Hellström M, Kristiansson M, Sterner G. Contrast-medium-induced nephropathy correlated to the ratio between dose in gram iodine and estimated GFR in ml/min. Acta Radiol 2005; 46: 830–42
   PubMed Web of Science ®Google Scholar
• Laskey WK, Jenkins C, Selzer F, Marroquin OC, Wilensky RL, Glaser R, et al. Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention. J Am Coll Cardiol 2007; 50: 584–90
   PubMed Web of Science ®Google Scholar
• Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31–41
   PubMed Web of Science ®Google Scholar
• Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358–67
   PubMed Web of Science ®Google Scholar
• Hosmer D, Lemeshow S. Applied logistic regression. Wiley, New York 2000
   Google Scholar
• Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 839–43
   PubMed Web of Science ®Google Scholar
• Frennby B, Sterner G. Contrast media as markers of GFR. Eur Radiol 2002; 12: 475–84
   PubMed Web of Science ®Google Scholar
• Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function—measured and estimated glomerular filtration rate. N Engl J Med 2006; 354: 2473–83
   PubMed Web of Science ®Google Scholar
• Nyman U, Björk J, Sterner G, Bäck SE, Carlson J, Lindström V, et al. Standardization of p-creatinine assays and use of lean body mass allow improved prediction of calculated glomerular filtration rate in adults: a new equation. Scand J Clin Lab Invest 2006; 66: 451–68
   PubMed Web of Science ®Google Scholar
• Björk J, Bäck SE, Sterner G, Carlson J, Lindström V, Bakoush O, et al. Prediction of relative glomerular filtration rate in adults: new improved equations based on Swedish Caucasians and standardized plasma-creatinine assays. Scand J Clin Lab Invest 2007; 67: 678–95
   PubMed Web of Science ®Google Scholar
• McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997; 103: 368–75
   PubMed Web of Science ®Google Scholar
• Duncan L, Heathcote J, Djurdjev O, Levin A. Screening for renal disease using serum creatinine: who are we missing?. Nephrol Dial Transplant 2001; 16: 1042–6
   PubMed Web of Science ®Google Scholar
• Voss R, Grebe M, Heidt M, Erdogan A. Use of gadobutrol in coronary angiography. Catheter Cardiovasc Interv 2004; 63: 319–22
   Google Scholar
• Gupta R, Uretsky BF. Gadodiamide-based coronary angiography in a patient with severe renal insufficiency. J Interv Cardiol 2005; 18: 379–83
   Google Scholar
• Elmståhl, B. Are gadolinium contrast media really less nephrotoxic than iodine agents in radiographic examinations? A comparison in relation to their ability to attenuate x-rays in a pig model. Lund University Faculty of Medicine Doctorial Dissertation Series 2006:9. Available at URL:, , http://luur.lub.lu.se/luur?func=downloadFile&fileOId=546104. (accessed January 22, 2008).
   Google Scholar
• Heinrich MC, Kuhlmann MK, Kohlbacher S, Scheer M, Grgic A, Heckmann MB, et al. Cytotoxicity of iodinated and gadolinium-based contrast agents in renal tubular cells at angiographic concentrations: in vitro study. Radiology 2007; 242: 425–34
   PubMed Web of Science ®Google Scholar
• Nyman, U, Elmståhl, B, Leander, P, Nilsson, M, Golman, K, Almen, T. Are gadolinium-based contrast media really safer than iodinated media for digital subtraction angiography in patients with azotemia?. Radiology 2002;223:311–8; discussion 28–9.
   PubMed Web of Science ®Google Scholar
• Medicines and Healthcare Products Regulatory Agency, United Kingdom. Nephrogenic systemic fibrosis (NSF) with gadolinium-containing magnetic resonance imaging (MRI) contrast agents – Update 26 June, 2007. Public Assessment Report. Increased risk of nephrogenic fibrosing dermopathy/nephrogenic fibrosis and gadolinium MRI contrast agents. Available at URL:, , http://www.mhra.gov.uk/Safetyinformation/Safetywarningsalertsandrecalls/Safetywarningsandmessagesformedicines/CON2030229 ( accessed April 7, 2008).
   Google Scholar
• Cigarroa RG, Lange RA, Williams RH, Hillis LD. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 1989; 86: 649–52
   PubMed Web of Science ®Google Scholar
• Morcos SK, Thomsen HS, Webb JA. Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur Radiol 1999; 9: 1602–13
   PubMed Web of Science ®Google Scholar